Prostrate cancer
FEATURED STORY 
BT Correspondent
KEMRI researcher joins global effort to probe causes of prostrate cancer
Researchers from the University of Birmingham, the University of Nottingham, and the Kenya Medical Research Institute (KEMRI) will investigate the importance of immune...
BT Correspondent
FEATURED STORY 
Brenda Gamonde
Boost for prostrate cancer patients as NHIF covers access to key drug
The National Health and Insurance Funds (NHIF) has added Zytiga (Abiraterone), a prostrate cancer drug that costs approximately Sh100,000 to the scheme. This...
Brenda Gamonde
